➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
McKesson
Express Scripts
Boehringer Ingelheim
Moodys

Last Updated: August 3, 2020

DrugPatentWatch Database Preview

CETIRIZINE HYDROCHLORIDE ALLERGY Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Cetirizine Hydrochloride Allergy patents expire, and what generic alternatives are available?

Cetirizine Hydrochloride Allergy is a drug marketed by Apotex, Aurobindo Pharma Ltd, Bionpharma Inc, Strides Pharma, Sun Pharm Inds Inc, Perrigo R And D, Amneal Pharms Ny, Apotex Inc, Cipla Ltd, Contract Pharmacal, Dr Reddys Labs Ltd, Granules India Ltd, Heritage Pharma, Ipca Labs Ltd, Marksans Pharma, Mylan, Orchid Hlthcare, Pld Acquisitions, Sun Pharm Inds Ltd, Taro, Torrent Pharms Llc, Unichem, Unique Pharm Labs, and Wockhardt. and is included in twenty-seven NDAs.

The generic ingredient in CETIRIZINE HYDROCHLORIDE ALLERGY is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and thirty-three suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.

US ANDA Litigation and Generic Entry Outlook for Cetirizine Hydrochloride Allergy

A generic version of CETIRIZINE HYDROCHLORIDE ALLERGY was approved as cetirizine hydrochloride by TEVA PHARMS on May 27th, 2008.

  Start Trial

Drug patent expirations by year for CETIRIZINE HYDROCHLORIDE ALLERGY
Recent Clinical Trials for CETIRIZINE HYDROCHLORIDE ALLERGY

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityPhase 4
Ciusss de L'Est de l'Île de MontréalPhase 3
TerSera TherapeuticsPhase 2

See all CETIRIZINE HYDROCHLORIDE ALLERGY clinical trials

Pharmacology for CETIRIZINE HYDROCHLORIDE ALLERGY

US Patents and Regulatory Information for CETIRIZINE HYDROCHLORIDE ALLERGY

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro CETIRIZINE HYDROCHLORIDE ALLERGY cetirizine hydrochloride TABLET;ORAL 078072-003 Jul 22, 2009 OTC No No   Start Trial   Start Trial   Start Trial
Perrigo R And D CETIRIZINE HYDROCHLORIDE ALLERGY cetirizine hydrochloride TABLET;ORAL 078336-001 Dec 27, 2007 OTC No No   Start Trial   Start Trial   Start Trial
Wockhardt CETIRIZINE HYDROCHLORIDE ALLERGY cetirizine hydrochloride TABLET;ORAL 078427-004 Dec 28, 2007 OTC No No   Start Trial   Start Trial   Start Trial
Unichem CETIRIZINE HYDROCHLORIDE ALLERGY cetirizine hydrochloride TABLET;ORAL 078680-004 Jun 26, 2009 OTC No No   Start Trial   Start Trial   Start Trial
Mylan CETIRIZINE HYDROCHLORIDE ALLERGY cetirizine hydrochloride TABLET;ORAL 076677-001 Dec 27, 2007 OTC No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Merck
Baxter
Express Scripts
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.